小儿咳嗽变异性哮喘120例临床研究.docVIP

小儿咳嗽变异性哮喘120例临床研究 　　【摘要】 目的：探?小儿咳嗽变异性哮喘的临床治疗方法。方法：选择2014年6月-2016年6月于笔者所在医院接受临床诊治的120例咳嗽变异性哮喘患儿为研究对象，按照随机数字法均分成观察组和对照组。对照组中的患儿治疗时均给予富马酸酮替芬，观察组中的患儿治疗时均给予布地奈德。治疗30 d后对比两组患儿的临床疗效。结果：观察组患儿的咳嗽缓解时间（5.76±1.52）d，咳嗽消失时间（11.18±3.45）d，住院时间（7.41±2.52）d，治疗费用（5123.14±523.14）元，均显著优于对照组的（9.17±2.41）d、（15.17±4.47）d、（12.17±3.55）d和（7163.06±625.11）元，组间差异均有统计学意义（P0.05）。结论：运用布地奈德吸入治疗咳嗽变异性哮喘可以显著提升临床治疗总有效率，加快患儿临床症状改善，相应的不良反应发生率也相对较低。 　　【关键词】 小儿； 咳嗽变异性哮喘； 布地奈德； 咳嗽 　　doi：10.14033/j.cnki.cfmr.2018.6.004 文献标识码 A 文章编号 1674-6805（2018）06-0009-03 　　Clinical Study on 120 Cases of Cough Variant Asthma in Children/HE Yantao.//Chinese and Foreign Medical Research，2018，16（6）：9-11 　　【Abstract】 Objective：To investigate the clinical treatment of cough variant asthma in children.Method：120 cases of children with cough variant asthma treated in our hospital from June 2014 to June 2016 were selected as the research object.They were divided into the observation group and the control group according to the random number method.The children in the control group were treated with Ketotifen Fumarate，and the children in the observation group were given Budesonide.After treatment of 30 d，the clinical efficacy of the two groups was compared.Result：The observation group cough relief time was （5.76±1.52）d，the disappearance time of cough was （11.18±3.45）d，hospitalization time was （7.41+2.52）d and the cost of treatment was （5 123.14±523.14）yuan，which were significantly better than those of the control group of （9.17±2.41）d，（15.17±4.47）d，（12.17±3.55）d and （7 163.06±625.11）yuan，the difference was statistically significant（P0.05）.Conclusion：The treatment of cough variant asthma with Budesonide Inhalation can significantly improve the total effective rate of clinical treatment，speed up the improvement of clinical symptoms in children，and the incidence of adverse reactions is relatively low. 　　【Key words】 Children； Cough variant asthma； Budesonide； Cough 　　First-author’s address：The People’s Hospital of Emeishan，Emeish